Menu Back to Committee

Meet the Program Commitee for 2023!

Program Committee

  • Sabine  Haubenreisser, PhD, MSc
    Sabine Haubenreisser, PhD, MSc Principal Scientific Administrator, Stakeholders and Communication Division
    European Medicines Agency, Netherlands
  • Karl  Broich, DrMed
    Karl Broich, DrMed President
    Federal Institute for Drugs and Medical Devices (BfArM), Germany
  • Natasha  Jarrett
    Natasha Jarrett Head Immunology, Infectious Disease, Ophthalmology, Neuroscience, Regulatory
    F. Hoffmann-La Roche Ltd., Switzerland
  • Indranil  Bagchi, PhD, MSc
    Indranil Bagchi, PhD, MSc Senior Vice President and Head, Global Value and Access
    Novartis Oncology, United States
  • Jan  Geissler, MBA
    Jan Geissler, MBA Managing Director
    Patvocates, Germany
  • Magda  Chlebus, MA
    Magda Chlebus, MA Executive Director, Science Policy & Regulatory Affairs
    EFPIA, Belgium
  • Anja  Schiel, PhD
    Anja Schiel, PhD Special Advisor, Lead Methodologist; Leader international HTA (iHTA) NoMA
    Norwegian Medicines Agency (NoMA), Norway
  • Ian  Hudson
    Ian Hudson Senior Advisor, Integrated Development
    Bill and Melinda Gates Foundation, United States
  • Patrick  Brady, PharmD
    Patrick Brady, PharmD Head Regulatory Policy & Intelligence
    Bayer AG / Research & Development, Pharmaceuticals, Germany
  • Thomas  Brookland, MSc
    Thomas Brookland, MSc EU Data Policy Lead
    F. Hoffmann-La Roche Ltd., Switzerland
  • Jesper  Kjær, MS
    Jesper Kjær, MS Co-Chair, EMA/HMA Big Data Steering Group; Director of Data Analytics Centre
    Danish Medicines Agency (DKMA), Denmark
  • Thomas  Schindler, PhD
    Thomas Schindler, PhD Director Medical Writing
    BioNTech, Germany
  • Derek   Johnston
    Derek Johnston QA Director, Regulatory Intelligence Office
    Labcorp Drug Development, United Kingdom
  • Lucia  D'Apote, DrSc, RAC
    Lucia D'Apote, DrSc, RAC Executive Director Global Regulatory and R&D Policy (ELMAC and JAPAC)
    Amgen, United Kingdom
  • Ursula  Busse, PhD, MBA
    Ursula Busse, PhD, MBA Head of Regulatory Affairs
    Tigen Pharma SA, Switzerland
  • Markus  Goese
    Markus Goese Head EU CMC Regulatory Policy
    F. Hoffmann-La Roche Ltd, Switzerland
  • Claudia  Hey, DrSc, PharmD
    Claudia Hey, DrSc, PharmD Senior Director, Head Europe Global Regulatory & Scientific Policy
    Merck Healthcare KGaA, Germany
  • Laura  Oliveira
    Laura Oliveira Regulatory Affairs, Director
    MSD Spain , Spain
  • Bjorg  Hunter, MSc
    Bjorg Hunter, MSc Director
    Novo Nordisk, Denmark
  • Tim  Chesworth
    Tim Chesworth Senior Director Regulatory Affairs
    AstraZeneca, United Kingdom
  • Francoise  Sillan, MD
    Francoise Sillan, MD VP GPS TA ENDO-ONCO & EU QPPV
    Ipsen, France
  • Phil  Tregunno
    Phil Tregunno Head of Vigilance Operations, Safety and Surveillance
    Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
  • Sina  Schader, DrMed
    Sina Schader, DrMed EU and UK QPPV
    Abbvie, Germany
  • Susanne  Ausborn, PhD
    Susanne Ausborn, PhD Global Head International Regulatory Policy
    F. Hoffmann-La Roche, Switzerland
  • Rodrigo  Palacios, MBA
    Rodrigo Palacios, MBA Regulatory Policy Lead
    F. Hoffmann-La Roche, Switzerland
  • Ronnie Harprit Mundair
    Ronnie Harprit Mundair Regional Labelling Head - AfME, Canada and LATAM - Senior Director
    Pfizer, United Kingdom
  • Edith  Frénoy, MA, MSc
    Edith Frénoy, MA, MSc Director, European Public Policy – Strategic EU Advocacy Lead
    MSD Europe Inc., Belgium
  • Wija  Oortwijn, PhD, MSc
    Wija Oortwijn, PhD, MSc Senior Scientific Researcher, Department for Health Evidence
    Radboud University Medical Centre, Netherlands
  • Aleksandar  Ruzicic
    Aleksandar Ruzicic President, Swiss Healthcare Industry Club (cHIC), INSEAD Alumni
    Association Switzerland & Vice President, INSEAD Healthcare Alumni Network, Switzerland
Load More